QSO Memo 20-15 (Revised 3/30/2020) – (Hospitals and CAHs)

Please share this announcement with individuals in the following roles: CEO, COO, CNO, Quality Director, Chief Medical Officer, Quality Director, Infection Control Coordinator, Emergency Preparedness Coordinator, Accreditation Coordinator CMS QSO-20-15 EMTALA Requirements and Implications Related to COVID-19 (Revised 3/30/2020) Key points: This publication provides additional guidance for the establishment of drive-through testing sites, clarification of…

Read more

QSO Memo 20-13 Revised (Hospitals and CAHs)

Please share this announcement with individuals in the following roles: CEO, COO, CNO, Chief Medical Officer Quality Director Infection Control Coordinator, Emergency Preparedness Coordinator, Accreditation Coordinator CMS QSO-20-13 Guidance for Infection Control and Prevention of COVID-19 – RevisedĀ  Key points: CMS has waived a number of requirements under Section 1135 of the Social Security Act…

Read more

FDA offers strategies for conservation of PPE

The U.S. Food and Drug Administration (FDA) has released a letter addressing conservation strategies for use by health care organizations and personnel for personal protective equipment (PPE), such as medical gloves; the strategies are categorized for a range of needs and supply levels and are intended to assist health care organizations as they determine procedures…

Read more

SURVEY ACTIVITY RESUMES WITH FOCUS ON INFECTION PREVENTION AND CONTROL

CMS announced on March 5, 2020 that the majority of deemed status surveys would be suspended due to the threat of COVID-19. This policy has been revised to allow hospital, CAH, and ASC surveys performed by HFAP and other accrediting organizations to resume. The four accreditation organizations (AO) with deeming authority for hospitals (HFAP, DNV,…

Read more